3/4
08:33 pm
amlx
Amylyx Pharmaceuticals Inc (AMLX) Q4 2025 Earnings Call Highlights: Strategic Advances and ... [Yahoo! Finance]
Medium
Report
Amylyx Pharmaceuticals Inc (AMLX) Q4 2025 Earnings Call Highlights: Strategic Advances and ... [Yahoo! Finance]
3/4
11:30 am
amlx
Amylyx Pharmaceuticals (AMLX) had its price target raised by HC Wainwright from $28.00 to $34.00. They now have a "buy" rating on the stock.
Low
Report
Amylyx Pharmaceuticals (AMLX) had its price target raised by HC Wainwright from $28.00 to $34.00. They now have a "buy" rating on the stock.
3/4
04:13 am
amlx
Amylyx Pharmaceuticals Says 2026 Could Be “Transformative” Ahead of Avexitide Phase 3 Readout [Yahoo! Finance]
Medium
Report
Amylyx Pharmaceuticals Says 2026 Could Be “Transformative” Ahead of Avexitide Phase 3 Readout [Yahoo! Finance]
3/4
12:34 am
amlx
Amylyx Refocuses On Avexatide As LUCIDITY Milestone Raises Stakes [Yahoo! Finance]
Medium
Report
Amylyx Refocuses On Avexatide As LUCIDITY Milestone Raises Stakes [Yahoo! Finance]
3/3
12:44 pm
amlx
Amylyx Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Low
Report
Amylyx Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
3/3
11:42 am
amlx
Amylyx Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
Neutral
Report
Amylyx Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
3/3
10:08 am
amlx
Amylyx (AMLX) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Amylyx (AMLX) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
3/3
08:03 am
amlx
Amylyx Pharmaceuticals (AMLX) is now covered by Stifel Nicolaus. They set a "buy" rating and a $21.00 price target on the stock.
Medium
Report
Amylyx Pharmaceuticals (AMLX) is now covered by Stifel Nicolaus. They set a "buy" rating and a $21.00 price target on the stock.
3/3
07:00 am
amlx
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
2/26
09:37 am
amlx
Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
Medium
Report
Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
2/26
09:00 am
amlx
Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences
Medium
Report
Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences
2/24
09:00 am
amlx
Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
Medium
Report
Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
2/20
08:03 am
amlx
Amylyx Pharmaceuticals (NASDAQ:AMLX) had its price target raised by analysts at Bank of America Corporation from $15.00 to $19.00. They now have a "buy" rating on the stock.
High
Report
Amylyx Pharmaceuticals (NASDAQ:AMLX) had its price target raised by analysts at Bank of America Corporation from $15.00 to $19.00. They now have a "buy" rating on the stock.
2/10
08:05 am
amlx
Amylyx Pharmaceuticals (NASDAQ:AMLX) had its price target raised by analysts at HC Wainwright from $20.00 to $28.00. They now have a "buy" rating on the stock.
Low
Report
Amylyx Pharmaceuticals (NASDAQ:AMLX) had its price target raised by analysts at HC Wainwright from $20.00 to $28.00. They now have a "buy" rating on the stock.
2/1
12:22 am
amlx
Amylyx Pharmaceuticals Co-Chief Executive Sells AMLX 138K Shares for $1.9 Million [Yahoo! Finance]
Medium
Report
Amylyx Pharmaceuticals Co-Chief Executive Sells AMLX 138K Shares for $1.9 Million [Yahoo! Finance]
1/29
05:05 pm
amlx
HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Medium
Report
HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
1/27
12:58 pm
amlx
Amylyx Pharmaceuticals: Back From The Dead [Seeking Alpha]
Low
Report
Amylyx Pharmaceuticals: Back From The Dead [Seeking Alpha]
1/19
08:26 am
amlx
Amylyx Nominates AMX0318 as Long-Acting GLP-1 Candidate for Rare Endocrine Disorders [Yahoo! Finance]
High
Report
Amylyx Nominates AMX0318 as Long-Acting GLP-1 Candidate for Rare Endocrine Disorders [Yahoo! Finance]
1/11
07:40 pm
amlx
Amylyx Pharmaceuticals (AMLX) Valuation Check As New GLP-1 Candidate AMX0318 Enters Development Stage [Yahoo! Finance]
Low
Report
Amylyx Pharmaceuticals (AMLX) Valuation Check As New GLP-1 Candidate AMX0318 Enters Development Stage [Yahoo! Finance]
1/10
03:11 pm
amlx
Amylyx Pharmaceuticals (AMLX) Announces the Selection of AMX0318 as Development Candidate for PBH and Other Rare Diseases [Yahoo! Finance]
Low
Report
Amylyx Pharmaceuticals (AMLX) Announces the Selection of AMX0318 as Development Candidate for PBH and Other Rare Diseases [Yahoo! Finance]
1/8
07:00 am
amlx
Amylyx Pharmaceuticals Announces Nomination of AMX0318 as a Novel, Long-Acting GLP-1 Receptor Antagonist Development Candidate, Identified in Collaboration with Gubra A/S
Medium
Report
Amylyx Pharmaceuticals Announces Nomination of AMX0318 as a Novel, Long-Acting GLP-1 Receptor Antagonist Development Candidate, Identified in Collaboration with Gubra A/S
12/20
01:30 am
amlx
Amylyx Pharmaceuticals (NASDAQ:AMLX) was downgraded by analysts at
Wall
Medium
Report
Amylyx Pharmaceuticals (NASDAQ:AMLX) was downgraded by analysts at
Wall
12/9
06:29 pm
amlx
Is Early AMX0114 Safety Data Altering The Investment Case For Amylyx Pharmaceuticals (AMLX)? [Yahoo! Finance]
Low
Report
Is Early AMX0114 Safety Data Altering The Investment Case For Amylyx Pharmaceuticals (AMLX)? [Yahoo! Finance]
12/5
09:00 am
amlx
Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of AMX0114 in ALS from First-in-Human LUMINA Trial
Medium
Report
Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of AMX0114 in ALS from First-in-Human LUMINA Trial